Skip to content

Clinical trials

Phase 1 Gastrointestinal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Phase 1 Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20063
20073
20082
20091
20101
20113
20122
20132
20146
20153
20162
20173
20187
20192
20205
20214
20226
20238
20248
20252
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting16
Unknown status14
Terminated7
Not yet recruiting6
Active, not recruiting5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
Boehringer Ingelheim4
Revolution Medicines, Inc.4
GlaxoSmithKline3
Curegenix Inc.2
Eisai Co., Ltd.2
M.D. Anderson Cancer Center2
Poniard Pharmaceuticals2
University of Utah2
AVEO Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms89
Colorectal Neoplasms28
Pancreatic Neoplasms20
Breast Neoplasms18
Neoplasms18
Lung Neoplasms17
Stomach Neoplasms17
Ovarian Neoplasms13
Head and Neck Neoplasms12
Colonic Neoplasms10

Trials

Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.